Ocugen, Inc. (OCGN)
1.34
-0.01
(-0.74%)
USD |
NASDAQ |
May 22, 16:00
1.33
-0.01
(-0.75%)
After-Hours: 20:00
Ocugen EPS Diluted (Quarterly) : -0.0586 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| REGENXBIO, Inc. | -1.718 |
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| Sarepta Therapeutics, Inc. | 2.878 |
| Krystal Biotech, Inc. | 1.833 |
| Gilead Sciences, Inc. | 1.612 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.18M |
| Revenue (Quarterly) | 1.533M |
| Total Expenses (Quarterly) | 20.71M |
| Enterprise Value | 455.06M |
| Gross Profit Margin (Quarterly) | 61.51% |
| Profit Margin (Quarterly) | -1.25K% |
| Earnings Yield | -17.30% |
| Normalized Earnings Yield | -17.29 |